Fundacion Instituto Valenciano De Oncologia
Fundacion Instituto Valenciano De Oncologia is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
Quantitative Unified Assessment of Novel Triplet therapy and Unconventional Maintenance with Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate Cancer: A Phase II Pilot Trial
Sponsor Alianza Multidisciplinar Para La Investigacion De Los Tumores Genitourinarios Guard
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
A Randomized, Multicenter, Open-label, Phase III Study of Lurbinectedin Single-Agent or Lurbinectedin in Combination with Irinotecan versus Investigator’s Choice (Topotecan or Irinotecan) in Relapsed Small Cell Lung Cancer (SCLC) Patients (LAGOON Trial)
Sponsor Pharma Mar S.A.
- Start (EU)
- Latest update
- Estimated end
Multicenter clinical trial with medical device associated with a drug in an authorised therapeutic use for the treatment of CVNMI evaluating the efficacy and tolerability of the adyuvant treatment with EMDA-MMC versus standard BCG in patients with high grade CVNMI
Sponsor Presurgy S.L.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Fundacion Instituto Valenciano De Oncologia?
The 2026-10-09 snapshot links Fundacion Instituto Valenciano De Oncologia to 3 distinct CTIS trials. Recorded services include Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Fundacion Instituto Valenciano De Oncologia?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Fundacion Instituto Valenciano De Oncologia conducted?
The linked trials record locations in 11 countries, including Spain, Austria, Belgium, Bulgaria, Germany. These are trial locations, not confirmed office locations or countries where Fundacion Instituto Valenciano De Oncologia delivered services.
What can this page tell me about Fundacion Instituto Valenciano De Oncologia's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Fundacion Instituto Valenciano De Oncologia. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Fundacion Instituto Valenciano De Oncologia